TNGX CIK: 1819133

Tango Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−59.5
FY22:
−109
FY23:
−118
FY24:
−132
FY25:
−139
Change from FY21 to FY25
millions USD
FY21:
−183
FY22:
26.4
FY23:
41.4
FY24:
86.1
FY25:
−40.9
Change from FY21 to FY25
millions USD
FY21:
357
FY22:
1.62
FY23:
82.4
FY24:
47.7
FY25:
223
millions USD
FY21:
114
FY22:
−81.1
FY23:
5.85
FY24:
2.29
FY25:
42.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−61.4
FY22:
−117
FY23:
−120
FY24:
−132
FY25:
−140

All amounts in millions USD Data source:SEC EDGAR